Hone Health vs LifeMD: Prices, Programs & Reviews (2026)
Side-by-side comparison updated for 2026. ClearScores, pricing, medications, and ratings compared.
Quick Verdict
Hone Health has the higher ClearScore (77 vs 76)
Hone Health is more affordable ($185/mo vs $199/mo)
LifeMD scores better on value (4.2/5 vs 3.3/5)
Hone Health
$185/mo
starting price
Lab-first GLP-1 prescribing plus hormone optimization. Compounded tirzepatide from $349/mo. $33M Series A.
LifeMD
$199/mo
starting price
Board-certified doctors prescribing GLP-1s with both compounded and brand-name options. Known for responsive customer service.
Hone Health vs LifeMD: Full Comparison
| Hone Health | LifeMD | |
|---|---|---|
| ClearScore | 77/100 ✓ | 76/100 |
| Overall Rating | 4.3/5 | 4.3/5 |
| Review Count | 10,400 ✓ | 165 |
| Starting Price | $185/mo ✓ | $199/mo |
| Medications | Compounded Tirzepatide, Compounded Liraglutide | Compounded Semaglutide, Compounded Tirzepatide |
| Telehealth | Yes | Yes |
| Insurance | Not accepted | Not accepted |
| HSA/FSA | Not accepted | Accepted |
| Founded | 2018 | 2020 |
| States Served | All 50 states | All 50 states |
Programs & Pricing
Hone Health Programs
Liraglutide Program
$185/mo total
Medications: Compounded Liraglutide
- Medication
- Membership
- Lab Work
- Clinician Access
Tirzepatide Program
$524/mo total
Medications: Compounded Tirzepatide
- Medication
- Membership
- Lab Work
- Clinician Access
LifeMD Programs
GLP-1 Weight Management
$199/mo
Medications: Compounded Semaglutide, Compounded Tirzepatide
- Medication
- Board Certified Doctor
- Ongoing Monitoring
- Free Shipping
Ratings Breakdown
| Category | Hone Health | LifeMD |
|---|---|---|
| Overall | | |
| Value | | |
| Ease of Use | | |
| Support | | |
| Medication Quality | | |
| Results | | |
The Bottom Line
Hone Health edges out LifeMD with a ClearScore of 77 vs 76. Hone Health is more affordable starting at $185/mo compared to $199/mo. For customer support, LifeMD rates higher (4.6/5). The best choice depends on your priorities, medication preferences, and budget.